GLP-1-Mediated Pregnancy and Neonatal Complications in Mice

Glucagon-like peptide 1 (GLP-1), a hormone derived from the proglucagon gene, regulates various physiological processes; however, its impact on pregnancy outcomes remains poorly understood. Assessing the effects of GLP-1 on neonates is vital as GLP-1 is increasingly administered during pregnancy. Th...

Full description

Bibliographic Details
Published in:	Journal of Developmental Biology
Main Authors:	Rajalakshmi Ramamoorthy, Arianna K. Carden, Hussain Hussain, Brian Z. Druyan, Ping Ping Chen, Rima Hajjar, Carmen Fernandez, Nila Elumalai, Amirah B. Rashed, Karen Young, Anna Rosa Speciale, Emily M. West, Staci Marbin, Bradley Safro, Ian J. Bishop, Arumugam R. Jayakumar, Luis Sanchez-Ramos, Michael J. Paidas
Format:	Article
Language:	English
Published:	MDPI AG 2025-08-01
Subjects:	A/J mice gene sequencing Glucagon-like peptide 1 neonatal complications pregnancy
Online Access:	https://www.mdpi.com/2221-3759/13/3/29

Similar Items

SPIKENET: An Evidence-Based Therapy for Long COVID
by: Nila Elumalai, et al.
Published: (2024-05-01)

Acute and Long COVID Intestinal Changes in an Experimental Model of Coronavirus in Mice
by: Hussain Hussain, et al.
Published: (2024-05-01)

Persistent Inflammation, Maladaptive Remodeling, and Fibrosis in the Kidney Following Long COVID-like MHV-1 Mouse Model
by: Rajalakshmi Ramamoorthy, et al.
Published: (2025-08-01)

Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
by: Dorte B. Zilstorff, et al.
Published: (2024-03-01)

Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs
by: Sina A. Gharib, et al.
Published: (2024-10-01)

Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity?
by: C. Meurot, et al.
Published: (2022-01-01)

GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
by: Nyan Abdalqadir, et al.
Published: (2022-10-01)

Effects of GLP-1 Receptor Polymorphisms on Adolescent Obesity
by: Mahafarin Maralani, et al.
Published: (2023-07-01)

The benefits of GLP1 receptors in cardiovascular diseases
by: Lamija Ferhatbegović, et al.
Published: (2023-12-01)

Acute activation of GLP-1-expressing neurons promotes glucose homeostasis and insulin sensitivity
by: Xuemei Shi, et al.
Published: (2017-11-01)

Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli
by: Cheney C, et al.
Published: (2025-05-01)

The protective role of GLP-1 in neuro-ophthalmology
by: Sohum Sheth, et al.
Published: (2023-08-01)

GLP-1 and Its Role in Glycogen Production: A Narrative Review
by: Joseph Lotosky, et al.
Published: (2025-06-01)

Dermatologic Changes in Experimental Model of Long COVID
by: Hussain Hussain, et al.
Published: (2024-01-01)

A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans
by: Brian Finan, et al.
Published: (2025-06-01)

The effects of GLP-1 agonists on HbA1c and insulin dose among patients with type 1 diabetes
by: Amirah Alhowiti, et al.
Published: (2025-08-01)

GLP-2 regulation of intestinal lipid handling
by: Kundanika Mukherjee, et al.
Published: (2024-02-01)

Foundational contributions of Svetlana Mojsov to the GLP-1 field
by: George Barany, et al.
Published: (2024-10-01)

Current and potential use of GLP-1R agonists: beyond type 2 diabetes
by: Graciela Zambrano-Galván, et al.
Published: (2024-10-01)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
by: Hoffman Simon, et al.
Published: (2024-08-01)

Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
by: Nadya M. Morrow, et al.
Published: (2021-09-01)

GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation
by: Jiani Zhong, et al.
Published: (2024-05-01)

Effects of exercise on glucagon-like peptide-1 (GLP-1)
by: Shin-ya Ueda, et al.
Published: (2013-06-01)

From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity
by: Svjatoslavs Kistkins, et al.
Published: (2024-05-01)

Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP‐1, GIP receptor agonists, and dual agonists
by: W. Timothy Garvey, et al.
Published: (2024-06-01)

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors
by: Jonas Ronn, et al.
Published: (2017-12-01)

Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism
by: Kyle D. Medak, et al.
Published: (2023-03-01)

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
by: Patrick J. Knerr, et al.
Published: (2022-09-01)

Effect and mechanism of GLP-1 on cognitive function in diabetes mellitus
by: Xiaoke Dou, et al.
Published: (2025-03-01)

GLP-1R signaling does not modify the severity of experimental graft versus host disease
by: Bernardo Yusta, et al.
Published: (2025-10-01)

Are obese rats influenced by GLP1 and IR through aerobic exercise? A case study
by: Ali Sayyah, et al.
Published: (2016-08-01)

GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy
by: Ahlima Roumane, et al.
Published: (2024-04-01)

The Neuroprotective Effects of GLP-1 Analogues on Alzheimer's Disease – A Literature Review
by: Wiktoria Ulicka, et al.
Published: (2025-04-01)

The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension
by: Hae Young Lee, et al.
Published: (2024-09-01)

The Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS
by: Aleksandra Jaroń, et al.
Published: (2024-08-01)

Dual activation of GCGR/GLP1R signaling ameliorates intestinal fibrosis via metabolic regulation of histone H3K9 lactylation in epithelial cells
by: Han Liu, et al.
Published: (2025-01-01)

Neuroprotective effects of GLP-1 class drugs in Parkinson’s disease
by: Dongliang Lv, et al.
Published: (2024-12-01)

The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology
by: Sofía Echeverry-Guerrero, et al.
Published: (2024-11-01)

Comparative Study on the Distribution of Glucagon-like Peptide-1 (GLP-1)-immunoreactive Cells in the Intestine of Chicken and Ostrich
by: Kohzy Hiramatsu, et al.
Published: (2003-01-01)

Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide
by: Celestine Odigwe, et al.
Published: (2025-04-01)